Ryan White Care Hepatitis C & B Language
NATAP Webinars
Successful Aging in People Living with HIV
Friday, September 20th, 2024 - 12:30pm
Click here to Register
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
CROI:
31st Conference on Retroviruses and Opportunistic Infection
Eric S. Daar, M.D. - Chief, Division of HIV Medicine Harbor-UCLA Medical Center Professor of Medicine David Geffen School of Medicine at UCLA - (03/26/24)
Patterns of HIV treatment preferences (oral, LA, implant…) among people with diverse demographic, social, and behavioral characteristics who are living with HIV in the United States
- (08/26/24)
Missed Opportunities: Characteristics of People Who Received a Concurrent HIV/AIDS Diagnosis in New York State From 2016 to 2021....19.0% had a CDX (late diagnosis)
- (08/26/24)
Switching to long-acting cabotegravir/rilpivirine: data from an Italian monocentric cohort
- (08/26/24)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
EASL:
Robust reduction of HBsAg and HDV RNA levels with low risk for ALT elevations in JNJ-73763989 treated patients with chronic hepatitis D (CHD) and baseline HBsAg levels below 10,000 IU/mL: Part 2 of the REEF-D study
- (06/18/24)
More Hep D Articles...
Aging & Perinatally Acquired HIV
The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study
- (09/09/24)
HRSA Issues Aging/HIV Letter on Older HIV; Long-Term Survivors in Ryan White HIV/AIDS Program
- (09/05/24)
HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis
- (09/03/24)
Aging with HIV - An Epidemiological Profile of Persons with Diagnosed HIV Aged 50 Years and Older in New York State, 2012-2021, new HIV more likely to have late diagnosis/stage 3 HIV, female white, heterosexual sex, IDU....heart disease/cancers leading cause of death NYC
- (08/26/24)
Prevalence and correlates of frailty among older people with and without HIV in rural Uganda
- (08/26/24)
THE ASSOCIATION OF ANEMIA WITH SURVIVAL AMONG PEOPLE WITH HIV FOLLOWING ANTIRETROVIRAL INITIATION IN THE NA-ACCORD 2007-2016
- (08/26/24)
IAS:
Negative Perception of Self & Stigma & Depression associated with Worse Expectations of Aging in Brazil
- (08/26/24)
More Aging & HIV Articles...
PrEP
Latino PrEP Barriers "Why Not Just go on PrEP?": A Study to Inform Implementation of an HIV Prevention Intervention Among Hispanic/Latino Men Who Have Sex With Men in the Northeastern United States
- (09/09/24)
IAS:
The DoxyPEP Debate: To DoxyPEP or not to DoxyPEP?
- (08/26/24)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
CBO Issues Paper: "A Call for New Research in the Area of Hepatitis C" creates inordinate barrier to HCV elimination
- (08/06/24)
CBO Statement: "Budgetary Effects of Policies That Would Increase Hepatitis C Treatment", creates impossible unique barrier to eliminate HCV
- (08/06/24)
Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City
- (08/02/24)
IAS:
HCV incidence among MSM using HIV PrEP and MSM with HIV in a New York City Health Care System over 2 decades
- (08/02/24)
IAS:
Community-Based HCV Self-Testing Widens Testing Access in Big Vietnam Study
- Mark Mascolini (07/27/24)
Medicaid Expansion and Restriction Policies for Hepatitis C Treatment
- (07/20/24)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
GSK receives US FDA Fast Track designation for bepirovirsen in chronic hepatitis B
- (08/12/24)
IAS:
Efficacy of dolutegravir/lamivudine (DTG/3TC) in adults with HIV-1 and isolated reactive hepatitis B core antibody (anti-HBc): results from the phase 3/3b GEMINI-1/-2, STAT, TANGO, and SALSA
- (07/31/24)
Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia - encourages earlier treatment in HBV monoinfection
- (07/10/24)
More Hep B Articles...
Fatty Liver, NAFLD, NASH
2nd New Fatty Liver Drug Pegozafermin in Phase 3
- (08/04/24)
Phase 3 Efuxifermin Fatty Liver/MASH Trial Ongoing; EASL 96 weeks HARMONY phase 2b study Results
- (08/04/24)
Steatotic liver disease and HIV: an agenda for 2030: 'PWH should be screened for fatty liver, steatosis'
- (07/10/24)
EASL:
Identification and validation of pre-identified morphological baseline features for prediction of fibrosis progression in MAESTRO-NASH
- (06/18/24)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
22 February 2024 - 23 February 2024 Nairobi Kenya
https://academicmedicaleducation.com/meeting/african-workshop-hiv-women-2024
May 2-4, 2024 Atlanta, GA
https://acthiv.org/acthiv-2024-program/
https://ddw.org/
https://easl.eu/event/easl-congress-2024/
https://asm.org/Events/ASM-Microbe/Home
Munich, Germany, and virtually from 22 to 26 July 2024.
Pre-conferences will be held on 20 and 21 July.
https://www.iasociety.org/conferences/aids2024
Conference on Liver Disease in Africa (COLDA) 2024
19 September 2024 - 21 September 2024 Egypt
https://academicmedicaleducation.com/meeting/conference-liver-disease-africa-colda-2024
18 September 2024 - 20 September 2024 Liverpool, United Kingdom
https://academicmedicaleducation.com/meeting/international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs-2024
https://www.iasociety.org/conferences/hivr4p2024/registration
https://idweek.org/#
24 October 2024 - 25 October 2024 United States
Washington DC, United States
https://academicmedicaleducation.com/meeting/international-workshop-hiv-aging-2024
10-13 November 2024
https://hivglasgow.org/
San Diego, California
https://www.aasld.org/liver-meeting-tlm-2024
https://informedhorizonseducation.com/hiv-respidart-2024
